Physician profile
Cornelia Holmes
NPI 1679961387
$3,757.05
in general payments reported to CMS, 2019-2025
19 companies · $590 in 2025
The $590 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $228 · 2021: $469 · 2022: $532 · 2023: $1,092 · 2024: $742 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,424.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $773.13 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $751.88 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $685.46 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $536.70 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $269.31 | 2020-2025 | |
| Redhill Biopharma INC. | $229.28 | 2021-2023 | Aemcolo, Talicia, Movantik |
| Exact Sciences Corporation | $117.75 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $65.79 | 2019-2022 | |
| Phadia US INC. | $49.08 | 2023-2024 | Immunocap |
| Abbott Laboratories | $45.61 | 2022 | |
| Abbvie INC. | $44.87 | 2021 | |
| Amgen INC. | $44.39 | 2020-2024 | Otezla, Repatha |
| Sanofi-Aventis U.S. LLC | $27.10 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $26.88 | 2023 | Jynarque |
| Edwards Lifesciences Corporation | $22.96 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $18.60 | 2020 | |
| Biomarin Pharmaceutical INC. | $18.39 | 2024 | Voxzogo 1.2mg |
| Hologic Sales and Service, LLC | $16.44 | 2022 | |
| Bard Peripheral Vascular, INC. | $13.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cornelia Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.